Vor Biopharma Inc. (VOR)
NASDAQ·Healthcare·Biotechnology
$14.33
+1.49%
Mkt Cap $96.78M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | — | — | — | -$1.14 | $82.04 | +7296.49% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$3.06 | -$3.33 | -8.82% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$11.40 | -$43.60 | -282.46% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.25 | -$0.26 | -4.00% | — | — |
| Q1 2025 Mar 20, 2025 | — | — | — | -$0.34 | -$0.44 | -29.41% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.40 | -$0.40 | +0.00% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.41 | -$0.41 | +0.00% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.37 | -$0.45 | -21.62% | — | — |
| Q1 2024 Mar 20, 2024 | — | $12.23M | — | -$0.49 | -$0.39 | +20.41% | — | — |
| Q4 2023 Nov 7, 2023 | — | — | — | -$0.46 | -$0.49 | -6.52% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.42 | -$0.45 | -7.14% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.38 | -$0.43 | -13.16% | — | — |
| Q1 2023 Mar 23, 2023 | — | — | — | -$0.56 | -$0.53 | +5.36% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$0.60 | -$0.63 | -5.00% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.67 | -$0.58 | +13.43% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.54 | -$0.61 | -12.96% | — | — |
| Q1 2022 Mar 14, 2022 | — | — | — | -$0.55 | -$0.49 | +10.91% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.58 | -$0.50 | +13.79% | — | — |
| Q3 2021 Aug 9, 2021 | — | — | — | -$0.47 | -$0.50 | -6.38% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$0.83 | -$0.67 | +19.28% | — | — |